Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

What’s New and What’s Next in the Treatment of MDS?
What’s New and What’s Next in the Treatment of MDS?
by paisley
Mikkael A. Sekeres, MD, MS. Professor of Medicine....
Treatment-related Adverse Effects in MDS:
Treatment-related Adverse Effects in MDS:
by emmy
Managing Them Before They Derail Therapy. Amy E. D...
Progress in MDS 2021 Guillermo Garcia-Manero MD
Progress in MDS 2021 Guillermo Garcia-Manero MD
by susan
Professor of Medicine. Chief Section of MDS. Deput...
Abnormal blood test Diagnosis of MDS
Abnormal blood test Diagnosis of MDS
by blanko
3 YEARS. Demographics of Germany. . [1910 – 205...
Bone Marrow Failure Diseases: Including MDS, AA, PNH
Bone Marrow Failure Diseases: Including MDS, AA, PNH
by elina
Lauren . Cosolo. , RN, BScN, MN. Outline. Review b...
EHA2021 Virtual Congress
EHA2021 Virtual Congress
by helene
Practice-changing abstracts in myelodysplastic syn...
Current Options and New Developments for Treating
Current Options and New Developments for Treating
by berey
Myelodysplastic. Syndromes. Oct 19, 2019. Myelody...
Eltrombopag for the Treatment of Thrombocytopenia of Low and Intermediate-1 IPSS Risk
Eltrombopag for the Treatment of Thrombocytopenia of Low and Intermediate-1 IPSS Risk
by cheeserv
Myelodysplastic. Syndromes: Interim Results on Ef...
Azacitidine use in post transplant relapse of MDS and AML
Azacitidine use in post transplant relapse of MDS and AML
by test
Jennifer Vaughn, MD. Bart Scott, MD. Myelodysplas...
Myelodysplastic Syndromes
Myelodysplastic Syndromes
by phoebe-click
Palak. Desai, MD. MDS. MDS comprises a group of ...
11/03/14 Personalized Approach in Acute and Chronic Leukemias
11/03/14 Personalized Approach in Acute and Chronic Leukemias
by kittie-lecroy
Emmanuel C. Besa, M.D.. Professor of Medical Onco...
Myelodysplastic Syndromes:
Myelodysplastic Syndromes:
by celsa-spraggs
Emerging Hope for a . Problematic Disease. John M...
Understanding Low Risk M
Understanding Low Risk M
by thomas
yelodysplastic syndromes (MDS). Adrienne A. Philli...
Bone Marrow Failure Syndromes
Bone Marrow Failure Syndromes
by pasty-toler
Brian Boulmay. , . MD. Bone Marrow Failure . In...
THALASSEMIA MINOR DIAGNOSTICS
THALASSEMIA MINOR DIAGNOSTICS
by carneos
BY A COMPUTATIONAL METHOD. Yulia Einav. Holon Inst...
Myelodysplastic syndromeGuru Subramanian Guru Murthy MDAssistant profe
Myelodysplastic syndromeGuru Subramanian Guru Murthy MDAssistant profe
by jalin
Clonal hematopoietic disorder multilineage hematop...
Comments from the Hebrew Rehabilitation Center on Aging HRCA
Comments from the Hebrew Rehabilitation Center on Aging HRCA
by stella
Suggestions for Modifications to Delirium Items fo...
Defining diagnostic brain MRI markers in early MSA
Defining diagnostic brain MRI markers in early MSA
by layla
Florian KRISMER, MD, . PhD. Department . of. . Ne...
Key Presentations from the 63rd American Society of Hematology (ASH) Annual Meeting:
Key Presentations from the 63rd American Society of Hematology (ASH) Annual Meeting:
by danya
Acute Myeloid Leukemia and Myelodysplastic Syndrom...
Recruitment of cancer patients by LCRN
Recruitment of cancer patients by LCRN
by karlyn-bohler
Subspecialty: Haem . Onc. & Lymphoma . Recr...
Hosted by Blood & Marrow Transplant Information Network (BMT
Hosted by Blood & Marrow Transplant Information Network (BMT
by oryan
InfoNet. ). Wednesday, October 27, 2021. Transplan...
Understanding Transplant for Bone Marrow Failure Diseases
Understanding Transplant for Bone Marrow Failure Diseases
by paige
Celalettin Ustun, MD. Rush University. Division of...
CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES
CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES
by susan
Rouslan Kotchetkov. ,. MD, PhD. 1. , Erin Ellison...
Inherited bone marrow failure syndromes
Inherited bone marrow failure syndromes
by amelia
Josu. de la . Fuente. Departments of Paediatrics ...
Lionel Adès
Lionel Adès
by trish-goza
Lenalidomide Combined to AZA in. Higher Risk MDS ...
Summary of the Movement Disorders Society Diagnostic Criter
Summary of the Movement Disorders Society Diagnostic Criter
by tatiana-dople
Postuma. RB, Berg D, Stern M, et al. MDS clinica...
Evolving Therapies for Elderly Patients with Blood Cancers
Evolving Therapies for Elderly Patients with Blood Cancers
by alida-meadow
Andrew Artz, MD, MS. Associate Professor of Medic...
Evolving Therapies for Elderly Patients with Blood Cancers
Evolving Therapies for Elderly Patients with Blood Cancers
by grewhypo
Andrew Artz, MD, MS. Associate Professor of Medici...
Naturopathic
Naturopathic
by okelly
1QandAWhatisMedicineNaturopathicmedicineisahealthc...
Akiko Shimamura, MD, PhD
Akiko Shimamura, MD, PhD
by ivy
Professor of Pediatrics, Harvard Medical School. D...
CLASSIFICATION OF AML &
CLASSIFICATION OF AML &
by VanillaSky
PROGNOSTIC FACTORS. Although the first published r...
Module 10: Myelodysplastic Syndromes,
Module 10: Myelodysplastic Syndromes,
by badra
Myeloproliferative Neoplasms and . Hematologic Dis...
Summary of the Movement Disorders Society Diagnostic Criteria
Summary of the Movement Disorders Society Diagnostic Criteria
by daniella
Postuma. RB, Berg D, Stern M, et al. MDS clinical...